JP2011037841A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011037841A5 JP2011037841A5 JP2010161144A JP2010161144A JP2011037841A5 JP 2011037841 A5 JP2011037841 A5 JP 2011037841A5 JP 2010161144 A JP2010161144 A JP 2010161144A JP 2010161144 A JP2010161144 A JP 2010161144A JP 2011037841 A5 JP2011037841 A5 JP 2011037841A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- solvate
- pharmaceutically acceptable
- acceptable salt
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 34
- 239000012453 solvate Substances 0.000 claims 34
- 150000001875 compounds Chemical class 0.000 claims 23
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 14
- 125000001424 substituent group Chemical group 0.000 claims 13
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 10
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 8
- 125000006621 (C3-C8) cycloalkyl-(C1-C6) alkyl group Chemical group 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 4
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims 4
- 206010058116 Nephrogenic anaemia Diseases 0.000 claims 4
- 208000007502 anemia Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000006553 (C3-C8) cycloalkenyl group Chemical group 0.000 claims 2
- 102000003951 Erythropoietin Human genes 0.000 claims 2
- 108090000394 Erythropoietin Proteins 0.000 claims 2
- 229940078467 Prolyl hydroxylase inhibitor Drugs 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 229940105423 erythropoietin Drugs 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 239000000411 inducer Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- SWAOUIZDHXCDEB-UHFFFAOYSA-N Cc1n[n](cccc2)c2n1 Chemical compound Cc1n[n](cccc2)c2n1 SWAOUIZDHXCDEB-UHFFFAOYSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010161144A JP5021797B2 (ja) | 2009-07-17 | 2010-07-16 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009169565 | 2009-07-17 | ||
| JP2009169565 | 2009-07-17 | ||
| JP2010161144A JP5021797B2 (ja) | 2009-07-17 | 2010-07-16 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012101381A Division JP2012144571A (ja) | 2009-07-17 | 2012-04-26 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011037841A JP2011037841A (ja) | 2011-02-24 |
| JP2011037841A5 true JP2011037841A5 (https=) | 2012-03-08 |
| JP5021797B2 JP5021797B2 (ja) | 2012-09-12 |
Family
ID=43449466
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010161144A Active JP5021797B2 (ja) | 2009-07-17 | 2010-07-16 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2012101381A Ceased JP2012144571A (ja) | 2009-07-17 | 2012-04-26 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2014207896A Pending JP2015003933A (ja) | 2009-07-17 | 2014-10-09 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2015239065A Pending JP2016040321A (ja) | 2009-07-17 | 2015-12-08 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2017134270A Expired - Fee Related JP6434575B2 (ja) | 2009-07-17 | 2017-07-10 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2018210486A Pending JP2019019144A (ja) | 2009-07-17 | 2018-11-08 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2020074508A Ceased JP2020111612A (ja) | 2009-07-17 | 2020-04-20 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2022104161A Ceased JP2022126843A (ja) | 2009-07-17 | 2022-06-29 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2024070200A Pending JP2024091878A (ja) | 2009-07-17 | 2024-04-24 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
Family Applications After (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012101381A Ceased JP2012144571A (ja) | 2009-07-17 | 2012-04-26 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2014207896A Pending JP2015003933A (ja) | 2009-07-17 | 2014-10-09 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2015239065A Pending JP2016040321A (ja) | 2009-07-17 | 2015-12-08 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2017134270A Expired - Fee Related JP6434575B2 (ja) | 2009-07-17 | 2017-07-10 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2018210486A Pending JP2019019144A (ja) | 2009-07-17 | 2018-11-08 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2020074508A Ceased JP2020111612A (ja) | 2009-07-17 | 2020-04-20 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2022104161A Ceased JP2022126843A (ja) | 2009-07-17 | 2022-06-29 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
| JP2024070200A Pending JP2024091878A (ja) | 2009-07-17 | 2024-04-24 | トリアゾロピリジン化合物、ならびにそのプロリル水酸化酵素阻害剤およびエリスロポエチン産生誘導剤としての作用 |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US8283465B2 (https=) |
| EP (3) | EP3594213A1 (https=) |
| JP (9) | JP5021797B2 (https=) |
| KR (5) | KR101850661B1 (https=) |
| CN (1) | CN102471337B (https=) |
| AR (1) | AR077417A1 (https=) |
| AU (1) | AU2010271732B2 (https=) |
| BR (1) | BR112012001157A2 (https=) |
| CA (1) | CA2768505C (https=) |
| CO (1) | CO6430426A2 (https=) |
| DK (1) | DK2455381T5 (https=) |
| ES (1) | ES2477968T3 (https=) |
| HR (1) | HRP20140705T1 (https=) |
| IL (1) | IL217541A (https=) |
| ME (1) | ME01858B (https=) |
| MX (1) | MX2012000766A (https=) |
| MY (1) | MY160814A (https=) |
| NZ (1) | NZ598242A (https=) |
| PE (1) | PE20120629A1 (https=) |
| PL (1) | PL2455381T3 (https=) |
| PT (1) | PT2455381E (https=) |
| RS (1) | RS53499B1 (https=) |
| RU (1) | RU2538963C2 (https=) |
| SG (1) | SG178049A1 (https=) |
| SI (1) | SI2455381T1 (https=) |
| SM (1) | SMT201500122B (https=) |
| TW (1) | TWI485150B (https=) |
| WO (1) | WO2011007856A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3594213A1 (en) * | 2009-07-17 | 2020-01-15 | Japan Tobacco Inc. | Triazolopyridine compounds and action thereof as prolyl hydroxylase inhibitors and erythropoietin production inducers |
| JP2011168582A (ja) * | 2010-01-21 | 2011-09-01 | Ishihara Sangyo Kaisha Ltd | トリアゾロピリジン誘導体又はその塩、それらの製造方法及びそれらを含有する有害生物防除剤 |
| WO2012065297A1 (en) * | 2010-11-16 | 2012-05-24 | Impact Therapeutics, Inc. | 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF |
| CN104936591B (zh) | 2012-11-26 | 2018-05-29 | 国立大学法人东北大学 | 促红细胞生成素表达增强剂 |
| JO3781B1 (ar) | 2012-12-24 | 2021-01-31 | Cadila Healthcare Ltd | مشتقات الكينولون |
| JP2016521747A (ja) | 2013-06-13 | 2016-07-25 | アケビア セラピューティクス インコーポレイテッドＡｋｅｂｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | 貧血治療のための組成物及び方法 |
| RU2534804C1 (ru) * | 2013-08-05 | 2014-12-10 | Общество С Ограниченной Ответственностью "Ньювак" (Ооо "Ньювак") | ЗАМЕЩЕННЫЕ [1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ, ПРОЯВЛЯЮЩИЕ СВОЙСТВА АНТАГОНИСТОВ АДЕНОЗИНОВЫХ А2А РЕЦЕПТОРОВ, И ИХ ПРИМЕНЕНИЕ |
| SG11201602572YA (en) * | 2013-10-03 | 2016-04-28 | Kura Oncology Inc | Inhibitors of erk and methods of use |
| WO2016034108A1 (zh) | 2014-09-02 | 2016-03-10 | 广东东阳光药业有限公司 | 喹啉酮类化合物及其应用 |
| JP2018039733A (ja) * | 2014-12-22 | 2018-03-15 | 株式会社富士薬品 | 新規複素環誘導体 |
| GB201504565D0 (en) * | 2015-03-18 | 2015-05-06 | Takeda Pharmaceutical | Novel compounds |
| CN106146395B (zh) * | 2015-03-27 | 2019-01-01 | 沈阳三生制药有限责任公司 | 3-羟基吡啶化合物、其制备方法及其制药用途 |
| EP4667059A3 (en) | 2015-05-28 | 2026-04-08 | Japan Tobacco Inc. | Method for treating or preventing diabetic nephropathy |
| KR102523786B1 (ko) * | 2016-11-25 | 2023-04-20 | 니뽄 다바코 산교 가부시키가이샤 | 트리아졸로피리딘 화합물의 제조 방법 |
| CA3062972C (en) * | 2017-05-09 | 2021-09-14 | Kind Pharmaceutical | Indolizine derivatives and their application in medicine |
| KR20200064101A (ko) * | 2017-10-04 | 2020-06-05 | 니뽄 다바코 산교 가부시키가이샤 | 질소 함유 헤테로아릴 화합물 및 그의 의약 용도 |
| CN107739378A (zh) * | 2017-11-14 | 2018-02-27 | 杭州安道药业有限公司 | 吲哚嗪衍生物及其在医药上的应用 |
| CA3106385A1 (en) | 2018-09-13 | 2020-03-19 | Kissei Pharmaceutical Co., Ltd. | Imidazopyridinone compound |
| CN110105355B (zh) * | 2019-05-24 | 2021-09-21 | 烟台大学 | 一种1,2,3-三唑-[1,5-a]并喹啉类化合物的制备方法 |
| KR20220152276A (ko) * | 2020-03-11 | 2022-11-15 | 깃세이 야쿠힌 고교 가부시키가이샤 | 이미다조피리디논 화합물 또는 그 염의 결정 |
| JP7504822B2 (ja) * | 2020-03-12 | 2024-06-24 | キッセイ薬品工業株式会社 | イミダゾピリジノン化合物を含む医薬組成物 |
| WO2021216530A1 (en) | 2020-04-20 | 2021-10-28 | Akebia Therapeutics, Inc. | Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizer |
| WO2022150623A1 (en) | 2021-01-08 | 2022-07-14 | Akebia Therapeutics, Inc. | Compounds and composition for the treatment of anemia |
| CN113387948B (zh) * | 2021-02-06 | 2022-06-10 | 成都诺和晟泰生物科技有限公司 | 一种稠环杂芳基衍生物及其药物组合物和治疗方法及用途 |
| EP4308120A4 (en) | 2021-03-19 | 2024-11-27 | Zydus Lifesciences Limited | TREATMENT OF SICKLE CELL ANEMIA |
| EP4347022A1 (en) | 2021-05-27 | 2024-04-10 | Keryx Biopharmaceuticals, Inc. | Pediatric formulations of ferric citrate |
| CN113582843A (zh) * | 2021-09-09 | 2021-11-02 | 无锡捷化医药科技有限公司 | 一种5-氯-2-氟-3-羟基苯甲酸乙酯的制备方法 |
| CN116496269B (zh) * | 2021-12-02 | 2025-02-28 | 苏中药业集团股份有限公司 | 一种脯氨酰羟化酶抑制剂及其用途 |
| CN114031619A (zh) * | 2021-12-17 | 2022-02-11 | 山东汇海医药化工有限公司 | 一种图卡替尼中间体的制备方法 |
| CN117327066A (zh) * | 2022-06-30 | 2024-01-02 | 上海济煜医药科技有限公司 | 一种新多晶型、其制备方法及其用于制备药物的用途 |
| JP2025529533A (ja) * | 2022-09-19 | 2025-09-04 | 蘇中薬業集団股▲ふん▼有限公司 | プロリルヒドロキシラーゼ阻害剤およびその用途 |
| TWI905781B (zh) * | 2023-06-02 | 2025-11-21 | 大陸商蘇中藥業集團股份有限公司 | 脯胺醯羥化酶抑制劑及其用途 |
| TW202506675A (zh) * | 2023-08-08 | 2025-02-16 | 美商富曼西公司 | 用於防治和對抗無脊椎有害生物的連接的雙環化合物 |
| WO2025087207A1 (zh) | 2023-10-24 | 2025-05-01 | 杭州安道药业有限公司 | 含有缺氧诱导因子-脯酰胺羟基化酶抑制剂的长效口服药物及其应用 |
| TW202529740A (zh) * | 2023-12-19 | 2025-08-01 | 美商阿克比治療有限公司 | Ｐｈｄ抑制劑化合物、組成物及使用方法 |
| WO2025167738A1 (zh) * | 2024-02-05 | 2025-08-14 | 深圳信立泰药业股份有限公司 | 化合物在制备治疗非髓系恶性肿瘤患者的贫血药物中的应用 |
| CN119700755B (zh) * | 2024-02-05 | 2026-01-30 | 深圳信立泰药业股份有限公司 | 化合物在制备预防和/或治疗高原病的药物中的应用 |
| CN119039291A (zh) * | 2024-09-09 | 2024-11-29 | 南京药坦生物科技有限公司 | 一种恩那度司他中间体及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19746287A1 (de) | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US6355653B1 (en) * | 1999-09-06 | 2002-03-12 | Hoffmann-La Roche Inc. | Amino-triazolopyridine derivatives |
| US6514989B1 (en) * | 2001-07-20 | 2003-02-04 | Hoffmann-La Roche Inc. | Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives |
| MXPA04003277A (es) * | 2001-10-08 | 2004-07-23 | Hoffmann La Roche | Amida del acido 8-amino-?1,2,4?triazolo?1,5-a?piridina-6-carboxilico. |
| US7544699B2 (en) | 2003-08-08 | 2009-06-09 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions, and methods of use |
| AU2005268893B2 (en) * | 2004-08-05 | 2011-10-13 | F. Hoffmann-La Roche Ag | Indole, indazole or indoline derivatives |
| FR2889383A1 (fr) * | 2005-08-01 | 2007-02-02 | France Telecom | Procede et dispositif de detection pour systeme mimo, systeme mimo, programme et support d'information |
| AR059733A1 (es) * | 2006-03-07 | 2008-04-23 | Smithkline Beecham Corp | Compuesto derivado de glicina n- sustituida con heteroaromaticos bicicicos, composicion farmaceutica que lo comprende, uso para preparar un medicamento para tratar la anemia y proceso para su preparacion |
| US20090176825A1 (en) | 2006-05-16 | 2009-07-09 | Fitch Duke M | Prolyl hydroxylase inhibitors |
| JO2934B1 (en) | 2006-06-23 | 2015-09-15 | سميث كلاين بيتشام كوربوريشن | Prolyl hydroxylase inhibitors |
| PL3357911T3 (pl) * | 2006-06-26 | 2022-09-05 | Akebia Therapeutics Inc. | Inhibitory prolilohydroksylazy i sposoby ich użycia |
| AU2007272009A1 (en) | 2006-07-12 | 2008-01-17 | Syngenta Limited | Triazolopyridine derivatives as herbicides |
| TW200845991A (en) | 2007-01-12 | 2008-12-01 | Smithkline Beecham Corp | N-substituted glycine derivatives: hydroxylase inhibitors |
| US8048894B2 (en) | 2007-04-18 | 2011-11-01 | Amgen Inc. | Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| EP2155746A2 (en) | 2007-05-04 | 2010-02-24 | Amgen, Inc | Diazaquinolones that inhibit prolyl hydroxylase activity |
| JP5408434B2 (ja) | 2007-07-03 | 2014-02-05 | アステラス製薬株式会社 | アミド化合物 |
| EA201000915A1 (ru) * | 2007-11-30 | 2011-02-28 | ГЛЭКСОСМИТКЛАЙН ЭлЭлСи | Ингибиторы пролилгидроксилазы |
| JP2011505367A (ja) * | 2007-11-30 | 2011-02-24 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | プロリルヒドロキシラーゼ阻害剤 |
| US8324241B2 (en) * | 2008-04-11 | 2012-12-04 | Bristol-Myers Squibb Company | Triazolo compounds useful as DGAT1 inhibitors |
| US20110039895A1 (en) * | 2008-04-30 | 2011-02-17 | Glaxo Smith Kline LLC., a corporation | Prolyl hydroxylase inhibitors |
| WO2009146358A1 (en) | 2008-05-29 | 2009-12-03 | Sirtris Pharmaceuticals, Inc. | Imidazopyridine and related analogs as sirtuin modulators |
| HRP20160488T1 (hr) | 2008-12-19 | 2016-06-17 | Leo Pharma A/S | Triazolopiridini kao inhibitori fosfodiesteraze za liječenje kožnih bolesti |
| EP3594213A1 (en) * | 2009-07-17 | 2020-01-15 | Japan Tobacco Inc. | Triazolopyridine compounds and action thereof as prolyl hydroxylase inhibitors and erythropoietin production inducers |
-
2010
- 2010-07-16 EP EP19188636.5A patent/EP3594213A1/en not_active Withdrawn
- 2010-07-16 BR BR112012001157A patent/BR112012001157A2/pt not_active Application Discontinuation
- 2010-07-16 EP EP10799914.6A patent/EP2455381B9/en active Active
- 2010-07-16 PT PT107999146T patent/PT2455381E/pt unknown
- 2010-07-16 KR KR1020177003353A patent/KR101850661B1/ko active Active
- 2010-07-16 TW TW099123410A patent/TWI485150B/zh active
- 2010-07-16 US US12/837,679 patent/US8283465B2/en active Active
- 2010-07-16 MX MX2012000766A patent/MX2012000766A/es active IP Right Grant
- 2010-07-16 ME MEP-2014-82A patent/ME01858B/me unknown
- 2010-07-16 RS RSP20140406 patent/RS53499B1/sr unknown
- 2010-07-16 HR HRP20140705AT patent/HRP20140705T1/hr unknown
- 2010-07-16 KR KR1020127004258A patent/KR101706803B1/ko active Active
- 2010-07-16 SI SI201030682T patent/SI2455381T1/sl unknown
- 2010-07-16 NZ NZ598242A patent/NZ598242A/xx unknown
- 2010-07-16 AR ARP100102614A patent/AR077417A1/es active IP Right Grant
- 2010-07-16 MY MYPI2012000223A patent/MY160814A/en unknown
- 2010-07-16 EP EP14160395.1A patent/EP2746282A1/en not_active Withdrawn
- 2010-07-16 RU RU2012105467/04A patent/RU2538963C2/ru active
- 2010-07-16 KR KR1020267000195A patent/KR20260012830A/ko active Pending
- 2010-07-16 DK DK10799914.6T patent/DK2455381T5/en active
- 2010-07-16 AU AU2010271732A patent/AU2010271732B2/en active Active
- 2010-07-16 WO PCT/JP2010/062037 patent/WO2011007856A1/ja not_active Ceased
- 2010-07-16 KR KR1020237040564A patent/KR20230165366A/ko not_active Ceased
- 2010-07-16 PL PL10799914T patent/PL2455381T3/pl unknown
- 2010-07-16 PE PE2012000056A patent/PE20120629A1/es active IP Right Grant
- 2010-07-16 ES ES10799914.6T patent/ES2477968T3/es active Active
- 2010-07-16 KR KR1020187010331A patent/KR20180042443A/ko not_active Ceased
- 2010-07-16 JP JP2010161144A patent/JP5021797B2/ja active Active
- 2010-07-16 SG SG2012003570A patent/SG178049A1/en unknown
- 2010-07-16 CN CN201080032238.2A patent/CN102471337B/zh active Active
- 2010-07-16 CA CA2768505A patent/CA2768505C/en active Active
-
2012
- 2012-01-15 IL IL217541A patent/IL217541A/en active IP Right Grant
- 2012-01-31 CO CO12014916A patent/CO6430426A2/es active IP Right Grant
- 2012-04-26 JP JP2012101381A patent/JP2012144571A/ja not_active Ceased
- 2012-09-06 US US13/605,329 patent/US20130096155A1/en not_active Abandoned
-
2014
- 2014-10-09 JP JP2014207896A patent/JP2015003933A/ja active Pending
-
2015
- 2015-05-22 SM SM201500122T patent/SMT201500122B/xx unknown
- 2015-06-25 US US14/749,966 patent/US20160145254A1/en not_active Abandoned
- 2015-12-08 JP JP2015239065A patent/JP2016040321A/ja active Pending
-
2017
- 2017-07-10 JP JP2017134270A patent/JP6434575B2/ja not_active Expired - Fee Related
-
2018
- 2018-11-08 JP JP2018210486A patent/JP2019019144A/ja active Pending
-
2020
- 2020-04-20 JP JP2020074508A patent/JP2020111612A/ja not_active Ceased
-
2022
- 2022-06-29 JP JP2022104161A patent/JP2022126843A/ja not_active Ceased
-
2024
- 2024-04-24 JP JP2024070200A patent/JP2024091878A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011037841A5 (https=) | ||
| RU2012105467A (ru) | Триазолопиридиновое соединение и его действие в качестве ингибитора пролилгидроксилазы и индуктора выработки эритропоэтина | |
| JP2010511721A5 (https=) | ||
| JP2019104748A5 (https=) | ||
| JP2014500870A5 (https=) | ||
| JP2012092103A5 (https=) | ||
| JP2019524883A5 (https=) | ||
| JP2016540742A5 (https=) | ||
| EA201070871A1 (ru) | Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии | |
| JP2014508811A5 (https=) | ||
| WO2009112678A3 (fr) | Derives de carboxam i d es azabicycliques, leur preparation et leur application en therapeutique. | |
| JP2012111953A5 (https=) | ||
| JP2013032389A5 (https=) | ||
| JP2016503797A5 (https=) | ||
| JP2012508252A5 (https=) | ||
| JP2013510120A5 (https=) | ||
| JP2013537203A5 (https=) | ||
| JP2010520214A5 (https=) | ||
| JP2015522650A5 (https=) | ||
| JP2013010731A5 (ja) | 複素環化合物 | |
| JP2013515037A5 (https=) | ||
| JP2015535847A5 (https=) | ||
| JP2013502441A5 (https=) | ||
| JP2018529690A5 (https=) | ||
| JP2012509265A5 (https=) |